programmes

Tuesday 26 March

KPMG, Hong Kong Central

Thursday 28 - Friday 29 March

Marriott City Centre, Shanghai

BIOTECH COMPANY SPOTLIGHT PRESENTATIONS

EARLY STAGE PROJECTS

  • Nanjing BioPoint - novel diagnostics for point of care – A/Prof David Anderson, President & CEO, Nanjing BioPoint Diagnostics, & Deputy Director, Burnet Institute

  • Novel cancer therapeutic targeting G9a – Dr Paul Madge, Business Development Associate, QIMR Berghofer Medical Research Institute

KEYNOTES

SPEAKERS

Lorraine Chiroiu CEO AusBiotech

Lorraine Chiroiu
CEO
AusBiotech

Dr Dan Grant CEO MTPConnect

Dr Dan Grant
CEO
MTPConnect

Eddie Liu Founder HY Capital

Eddie Liu
Founder
HY Capital

Judith Li Partner Lilly Asia Ventures

Judith Li
Partner
Lilly Asia Ventures

David Bennett Counsellor IP Australian Embassy Beijing

David Bennett
Counsellor IP
Australian Embassy Beijing

Sam Guthrie Senior Trade Commissioner Austrade

Sam Guthrie
Senior Trade Commissioner
Austrade

George Li Managing Partner Proxima Ventures

George Li
Managing Partner
Proxima Ventures

Ian Huen Founder, Chief Executive Officer and Executive Director Aptorum Group

Ian Huen
Founder, Chief Executive Officer
and Executive Director
Aptorum Group

James Ieong Head of IC, Chairman Pagoda Investment

James Ieong
Head of IC, Chairman
Pagoda Investment

Cyndi Zhai General Manager Joyin Life Science Incubators

Cyndi Zhai
General Manager
Joyin Life Science Incubators

Michael Chan Senior VP Market Development, Hong Kong Exchanges and Clearing Limited

Michael Chan
Senior VP Market Development,
Hong Kong Exchanges
and Clearing Limited

 

Presenting companies

Please see below a list of presenting companies for the Asian Investment Series in Hong Kong and Shanghai. Further companies will be added to the programme in the coming weeks.